agilon health inc. (AGL) vs DaVita (DVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
agilon health inc. (AGL) has outperformed DaVita (DVA) over the past year, gaining 481.3% versus a gain of 33.9%. Over five years, DVA leads with a +65.5% price change compared with -83.3% for AGL. DaVita is the larger company by market cap ($10.13 billion vs $1.52 billion), about 6.7 times the size.
On valuation, DaVita trades at a lower forward P/E (9.5x vs 20.7x for agilon health inc.). DaVita converts more of its revenue into profit, with a net margin of 5.5% versus -6.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AGL | DVA |
|---|---|---|
| Share price | $90.24 | $161.03 |
| Market cap | $1.52B | $10.13B |
| 1-day change | +0.83% | +3.00% |
| YTD return | +423.89% | +41.74% |
| 1-year return | +481.26% | +33.91% |
| 5-year return | -83.28% | +65.52% |
| P/E ratio (TTM) | — | 12.19 |
| Forward P/E | 20.70 | 9.52 |
| EPS (TTM) | $-6.69 | $13.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $5.93B | $13.64B |
| Revenue growth (YoY) | -2.11% | +6.46% |
| Net income (latest FY) | $-391.35M | $746.80M |
| Operating margin | -7.81% | 14.98% |
| Net margin | -6.60% | 5.47% |
| 52-week high | $133.04 | $247.49 |
| 52-week low | $7.48 | $101.00 |
| Distance from 52-week high | -32.17% | -34.93% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +38.33% | +38.04% |
| Average volume | 226.26K | 738.70K |
| Shares outstanding | 16.80M | 62.90M |
| Employees | 856 | 78,000 |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DaVita is about 6.7 times larger than agilon health inc. by market value ($10.13B vs $1.52B).
- AGL has outperformed DVA by 447.3 percentage points over the past year.
- DaVita is more profitable, keeping 5.5 cents of every revenue dollar as net income versus -6.6 cents for agilon health inc..
- DaVita grew revenue faster in its latest fiscal year (+6.46% vs -2.11%).
About agilon health inc.
AGL stock →agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States.
Health Care · Misc Health and Biotechnology Services · 856 employees
About DaVita
DVA stock →DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
Health Care · Misc Health and Biotechnology Services · 78,000 employees
AGL vs DVA FAQ
Which is bigger, agilon health inc. or DaVita?
DaVita (DVA) is larger, with a market capitalization of $10.13B compared with $1.52B for agilon health inc. (AGL).
Which stock has performed better over the past year, AGL or DVA?
AGL returned +481.26% over the past 12 months, compared with +33.91% for DVA (price return, excluding dividends). Past performance does not predict future results.
Are agilon health inc. and DaVita in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.